Viewing Study NCT04156659


Ignite Creation Date: 2025-12-24 @ 2:28 PM
Ignite Modification Date: 2026-02-25 @ 11:48 PM
Study NCT ID: NCT04156659
Status: WITHDRAWN
Last Update Posted: 2023-03-09
First Post: 2019-10-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Tisagenlecleucel in Chinese Pediatric and Young Adult Subjects With Relapsed or Refractory B-cell ALL
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None B-cell Acute Lymphoblastic Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia View
None ALL View
None Tisagenlecleucel View
None CTL019 View
None China View